CTI BIOPHARMA CORP Annual Nonoperating Income (Expense) in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Cti Biopharma Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2022.
  • Cti Biopharma Corp Nonoperating Income (Expense) for the quarter ending March 31, 2023 was -$4.19M, a 102% decline year-over-year.
  • Cti Biopharma Corp Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was -$15.3M, a 244% decline year-over-year.
  • Cti Biopharma Corp annual Nonoperating Income (Expense) for 2022 was -$13.2M, a 412% decline from 2021.
  • Cti Biopharma Corp annual Nonoperating Income (Expense) for 2021 was -$2.58M, a 45% increase from 2020.
  • Cti Biopharma Corp annual Nonoperating Income (Expense) for 2020 was -$4.68M, a 781% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$13.2M -$10.6M -412% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-06
2021 -$2.58M +$2.11M +45% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 -$4.68M -$5.37M -781% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $688K -$2.86M -80.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
2018 $3.55M +$4.86M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 -$1.31M +$2.48M +65.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 -$3.79M +$306K +7.47% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2015 -$4.1M +$3.9M +48.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 -$8M -$5.97M -295% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 -$2.02M -$1.83M -965% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-17
2012 -$190K +$239K +55.7% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 -$429K +$4M +90.3% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-04
2010 -$4.43M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.